Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramiro Garzon

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Leukemia|March 13, 2019
Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cellsMarius Bill, Dimitrios Papaioannou, Malith Karunasiri, et al.
Haematologica|May 13, 2021
Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the <i>MLL</i> geneMarius Bill, Chinmayee Goda, Felice Pepe, et al.
Journal of the National Cancer Institute|October 13, 2014
Pluripotent stem cell miRNAs and metastasis in invasive breast cancerStefano Volinia, Gerard Nuovo, Alessandra Drusco, et al.
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
<i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignanciesMehdi Hamadani, William Blum, Gary Phillips, et al.
Investigational New Drugs|May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLJae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
Blood|August 4, 2016
miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potencyYunjie Lu, Keli L Hippen, Amanda L Lemire, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Leukemia|March 13, 2019
Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cellsMarius Bill, Dimitrios Papaioannou, Malith Karunasiri, et al.
Haematologica|May 13, 2021
Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the <i>MLL</i> geneMarius Bill, Chinmayee Goda, Felice Pepe, et al.
Journal of the National Cancer Institute|October 13, 2014
Pluripotent stem cell miRNAs and metastasis in invasive breast cancerStefano Volinia, Gerard Nuovo, Alessandra Drusco, et al.
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
<i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignanciesMehdi Hamadani, William Blum, Gary Phillips, et al.
Investigational New Drugs|May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLJae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
Blood|August 4, 2016
miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potencyYunjie Lu, Keli L Hippen, Amanda L Lemire, et al.
Pageof 14